Home Non Invasive Ventilation (NIV) Treatment for COPD-patients After a NIV-treated Exacerbation

PHASE4UnknownINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2020

Conditions
Chronic Obstructive Pulmonary DiseaseAcute Exacerbation of Chronic Obstructive Airways DiseaseChronic Hypercapnic Respiratory Failure
Interventions
DEVICE

LTNIV

LTNIV with the ventilator and the settings and pressures which reversed the respiratory failure and the hypercapnic acidosis. We know the patients are able to tolerate these settings. The ventilators are Philips A30. The patients must use the ventilator for a minimum of six hours a night.

Trial Locations (4)

DK-2900

RECRUITING

Dept. of Pulmonary Medicine Y, UH Gentofte, Hellerup

DK-2730

RECRUITING

Dept. of Internal Medicine O, UH Herlev, Herlev

DK-2650

RECRUITING

Dept. of Pulmonary Medicine and Cardiology, UH Hvidovre, Hvidovre

DK-2400

RECRUITING

Dept. of Pulmonary Medicine, L, UH Bispebjerg, København NV

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Philips Respironics

INDUSTRY

lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT01513655 - Home Non Invasive Ventilation (NIV) Treatment for COPD-patients After a NIV-treated Exacerbation | Biotech Hunter | Biotech Hunter